• Register
  • Login

European Journal of Molecular & Clinical Medicine

  1. Home
  2. Features of the Metabolic Syndrome and Type 2 Diabetes Mellitus in Schizotypal Disorder

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

About Journal

Aims and Scope

Editorial Board

Publication Ethics

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

Journal Metrics

News

Features of the Metabolic Syndrome and Type 2 Diabetes Mellitus in Schizotypal Disorder

    Authors

    • Oleg V. Ermilov 1
    • Andrey Yu. Tretyakov 2
    • Lyubov V. Romasenko 3
    • Nina I. Zhernakova 2
    • Elizaveta S. Rudycheva 2
    • Inna V. Tikhonova 2
    • Irina A. Misan 2

    1 Belgorod State University, Medical Institute Department of medicine and Pediatrics, 85, Pobedy St., Belgorod, 308015, Russia Belgorod Region Clinical Hospital of Saint Ioasaf, 8/9, Nekrasov St., Belgorod, 308007, Russia,

    2 Belgorod State University, Medical Institute Department of medicine and Pediatrics, 85, Pobedy St., Belgorod, 308015, Russia

    3 The Serbsky State Scientific Center for Social and Forensic Psychiatry, 23, Kropotkinskij per., Moscow, 119034, Russia

,

Document Type : Research Article

  • Article Information
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

Objective: To describe the features and mechanisms of development of metabolic
syndrome (MS), type 2 diabetes melitus (DM2) and intermediate states of glycemia in
psychosis the occurrence of these disorders, the values of total cholesterol (TC),
fractions of high density lipoproteins (HDL), very low density lipoproteins (VLDL),
triglycerides (TG), values of atherogenic coefficient (AC), insulinemia, С-peptidemia,
insulin resistance (IR) the level of glycated hemoglobin (HbA1c) in a sample of patients
with schizophrenia and in mentally healthy individuals.
Materials and methods: The frequency of carbohydrate metabolism disorders (CMD) was
studied. Fasting glycemia was determined, and in the presence of its violation, a glucose
tolerance test was performed. MS components were studied in patients with DM2,
plasma concentrations of TC, HDL, VLDL, TG, C-peptide (CP), insulin and HbA1c were
determined in patients with DM2, AC values and IR indices were calculated using
HOMA-IR and CARO criteria.
Results: CMD in schizophrenia are more common than among mentally healthy subjects,
amounting to 13.1% (p=0.02), and the main condition here is a significant number of
individuals with impaired fasting glycemia (IFG) and impaired glucose tolerance (IGT)
among women (CMD p=0.01; IGT p<0.001; IFG p=0.03). A feature of psychiatric
sampling is a decrease in HDL by 16.4% (p=0.03) and an increase in AC by 52%
(p=0.02). Mentally ill men with MS are characterized by a significantly large value of AC
(p=0.019), insulinemia (p=0.02), CP level (p=0.02), HOMA-IR (p=0.01) and CARO
(p=0.04) values than in mentally ill patients with DM2 without MS. In comparison with
the control, regardless of gender, the schizophrenic patients with DM2 have significantly
lower values of insulin (p=0.03), C-peptidemia (p=0.04) and IR, according to the criteria of
HOMA-IR (p=0.01) and CARO (p=0.03).

Keywords

  • Schizophrenia
  • metabolic syndrome
  • diabetes mellitus
  • Dyslipidemia
  • Insulin
  • Insulin resistance
  • C-peptide
  • Glycated Hemoglobin
  • XML
  • PDF 637.23 K
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
    • Article View: 347
    • PDF Download: 353
European Journal of Molecular & Clinical Medicine
Volume 7, Issue 2
November 2020
Page 122-127
Files
  • XML
  • PDF 637.23 K
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 347
  • PDF Download: 353

APA

Ermilov, O. V., Tretyakov, A. Y., Romasenko, L. V., Zhernakova, N. I., Rudycheva, E. S., Tikhonova, I. V., & Misan, I. A. (2020). Features of the Metabolic Syndrome and Type 2 Diabetes Mellitus in Schizotypal Disorder. European Journal of Molecular & Clinical Medicine, 7(2), 122-127.

MLA

Oleg V. Ermilov; Andrey Yu. Tretyakov; Lyubov V. Romasenko; Nina I. Zhernakova; Elizaveta S. Rudycheva; Inna V. Tikhonova; Irina A. Misan. "Features of the Metabolic Syndrome and Type 2 Diabetes Mellitus in Schizotypal Disorder". European Journal of Molecular & Clinical Medicine, 7, 2, 2020, 122-127.

HARVARD

Ermilov, O. V., Tretyakov, A. Y., Romasenko, L. V., Zhernakova, N. I., Rudycheva, E. S., Tikhonova, I. V., Misan, I. A. (2020). 'Features of the Metabolic Syndrome and Type 2 Diabetes Mellitus in Schizotypal Disorder', European Journal of Molecular & Clinical Medicine, 7(2), pp. 122-127.

VANCOUVER

Ermilov, O. V., Tretyakov, A. Y., Romasenko, L. V., Zhernakova, N. I., Rudycheva, E. S., Tikhonova, I. V., Misan, I. A. Features of the Metabolic Syndrome and Type 2 Diabetes Mellitus in Schizotypal Disorder. European Journal of Molecular & Clinical Medicine, 2020; 7(2): 122-127.

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by ejournalplus